Efficacy in wound healing of IDR-1018 peptide in a murine dose-response model.

<p>Peptides were administered every 48 hours with the indicated concentrations of IDR-1018 or PBS (negative control). Re-epithelialization/wound closure was measured every second day. Standard deviation was assessed as SEM (Superscript symbols *, ⁺, and ^∼ represent 15 µl doses of 3, 0.3 and 0.03 µg respectively; *,+,∼ = p<0.05; **,++,∼∼ = p<0.01; ***,+++,∼∼∼ = p<0.005 compared to vehicle control).